Compugen (CGEN) Assets (2009 - 2026)
Compugen (CGEN) posted quarterly Assets of $145.9 million for Q1 2026, up 26.35% year-over-year from $115.4 million in Q1 2025, and down 6.84% on a QoQ basis from $156.6 million in Q4 2025.
Compugen (CGEN) Assets (2009 - 2026) Analysis & Trends
Compugen has reported Assets for 18 years, with the latest figure at $145.9 million in Q1 2026.
- Assets for Q1 2026 came in at $145.9 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.9 million (up 26.35% YoY), and the FY2025 annual result was $156.6 million, up 36.15% from the prior year.
- Assets slipped to $145.9 million in Q1 2026, from $156.6 million in the prior quarter.
- Over five years, Assets peaked at $156.6 million in Q4 2025 and troughed at $67.6 million in Q3 2023.
- A 5-year average of $109.4 million and a median of $110.3 million in 2022 frame the typical range for Assets.
- The widest annual swing landed in 2023, when Assets slumped 31.96%; it then jumped 82.69% in 2024.
- A 5-year view of Assets shows it stood at $94.2 million in 2022, then advanced by 28.84% to $121.3 million in 2023, then slipped by 5.22% to $115.0 million in 2024, then surged by 36.15% to $156.6 million in 2025, then decreased by 6.84% to $145.9 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $145.9 million in Q1 2026, $156.6 million in Q4 2025, and $97.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 145.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.86 Mn |
| Dec 31, 2025 | 156.57 Mn |
| Sep 30, 2025 | 97.85 Mn |
| Jun 30, 2025 | 106.53 Mn |
| Mar 31, 2025 | 115.44 Mn |
| Dec 31, 2024 | 115.00 Mn |
| Sep 30, 2024 | 123.52 Mn |
| Jun 30, 2024 | 110.17 Mn |
| Mar 31, 2024 | 113.70 Mn |
| Dec 31, 2023 | 121.33 Mn |
| Sep 30, 2023 | 67.61 Mn |
| Jun 30, 2023 | 77.06 Mn |
| Mar 31, 2023 | 84.32 Mn |
| Dec 31, 2022 | 94.18 Mn |
| Sep 30, 2022 | 99.37 Mn |
| Jun 30, 2022 | 110.31 Mn |
| Mar 31, 2022 | 120.93 Mn |
| Dec 31, 2021 | 132.16 Mn |
| Sep 30, 2021 | 121.30 Mn |
| Jun 30, 2021 | 122.82 Mn |